SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-028010
Filing Date
2016-07-29
Accepted
2016-07-29 15:12:02
Documents
2
Period of Report
2016-07-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1765
2 POWER OF ATTORNEY ex24bate.txt EX-24 4969
  Complete submission text file 0001179110-16-028010.txt   8090
Mailing Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE, SUITE 400 FORT WASHINGTON PA 19034 610-527-6790
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILLENNIUM PHARMACEUTICALS INC 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
BATE KENNETH (Reporting) CIK: 0001210238 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 161793770